{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:13:56Z","timestamp":1780636436599,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402606"],"award-info":[{"award-number":["81402606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["cstc2017jcyjAX0220"],"award-info":[{"award-number":["cstc2017jcyjAX0220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ajpath.2019.04.012","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T20:36:41Z","timestamp":1558125401000},"page":"1582-1593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Progranulin Promotes Bleomycin-Induced Skin Sclerosis by Enhancing Transforming Growth Factor\u2013\u03b2\/Smad3 Signaling through Up-Regulation of Transforming Growth Factor\u2013\u03b2 Type I Receptor"],"prefix":"10.1016","volume":"189","author":[{"given":"Ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunju","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengzeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2019.04.012_bib1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(06)68737-0","article-title":"Systemic sclerosis: hypothesis-driven treatment strategies","volume":"367","author":"Charles","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2019.04.012_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2019.04.012_bib3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.it.2005.09.004","article-title":"Scleroderma: from cell and molecular mechanisms to disease models","volume":"26","author":"Abraham","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jbiomech.2009.09.020","article-title":"The myofibroblast: paradigm for a mechanically active cell","volume":"43","author":"Hinz","year":"2010","journal-title":"J\u00a0Biomech"},{"key":"10.1016\/j.ajpath.2019.04.012_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/BOR.0b013e3283524b9a","article-title":"Innovative antifibrotic therapies in systemic sclerosis","volume":"24","author":"Beyer","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor beta-at the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7555\/JBR.31.20170034","article-title":"Transforming growth factor-beta signaling in systemic sclerosis","volume":"32","author":"Ayers","year":"2018","journal-title":"J Biomed Res"},{"key":"10.1016\/j.ajpath.2019.04.012_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cyto.2016.08.007","article-title":"Progranulin: a key player in autoimmune diseases","volume":"101","author":"Jian","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.ajpath.2019.04.012_bib10","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/art.39312","article-title":"Progranulin overproduction due to Fli-1 deficiency contributes to the resistance of dermal fibroblasts to tumor necrosis factor in systemic sclerosis","volume":"67","author":"Ichimura","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm816","article-title":"Progranulin is a mediator of the wound response","volume":"9","author":"He","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2019.04.012_bib12","doi-asserted-by":"crossref","first-page":"26323","DOI":"10.18632\/oncotarget.15461","article-title":"Tumor necrosis factor receptor 2\/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2019.04.012_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yexmp.2015.11.021","article-title":"PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts","volume":"100","author":"Dong","year":"2016","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1126\/science.1199214","article-title":"The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice","volume":"332","author":"Tang","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2019.04.012_bib15","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1136\/annrheumdis-2014-205779","article-title":"Progranulin protects against osteoarthritis through interacting with TNF-alpha and beta-Catenin signalling","volume":"74","author":"Zhao","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajpath.2019.04.012_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jdermsci.2018.09.005","article-title":"Progranulin overproduction due to constitutively activated c-Abl\/PKC-delta\/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-alpha in localized scleroderma","volume":"92","author":"Miyagawa","year":"2018","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ajpath.2019.04.012_bib17","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/art.23645","article-title":"The controversial role of tumor necrosis factor alpha in fibrotic diseases","volume":"58","author":"Distler","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2019.04.012_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","article-title":"Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma","volume":"112","author":"Yamamoto","year":"1999","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ajpath.2011.09.013","article-title":"Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma","volume":"180","author":"Kitaba","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1042\/CS20180243","article-title":"The preventive and therapeutic implication for renal fibrosis by targetting TGF-beta\/Smad3 signaling","volume":"132","author":"Zhang","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ajpath.2019.04.012_bib21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbrc.2018.06.072","article-title":"SIS3, a specific inhibitor of smad3, attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"503","author":"Shou","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2019.04.012_bib22","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.ajpath.2017.05.005","article-title":"Adenosine A2a receptor blockade diminishes Wnt\/beta-catenin signaling in a murine model of bleomycin-induced dermal fibrosis","volume":"187","author":"Zhang","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2230.2011.04275.x","article-title":"Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma","volume":"37","author":"Huang","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","article-title":"Toll-like receptor 4 signaling augments transforming growth factor-beta responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma","volume":"182","author":"Bhattacharyya","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/imm.12446","article-title":"Progranulin is preferentially expressed in patients with psoriasis vulgaris and protects mice from psoriasis-like skin inflammation","volume":"145","author":"Huang","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.ajpath.2019.04.012_bib26","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/art.37907","article-title":"CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma","volume":"65","author":"Vorstenbosch","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2019.04.012_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s13238-015-0171-3","article-title":"Involvement of collagen-binding heat shock protein 47 in scleroderma-associated fibrosis","volume":"6","author":"Chu","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.ajpath.2019.04.012_bib28","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.0022-202X.2004.22323.x","article-title":"Interleukin 6 indirectly induces keratinocyte migration","volume":"122","author":"Gallucci","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/clim.2001.5169","article-title":"Animal model of sclerotic skin induced by bleomycin: a clue to the pathogenesis of and therapy for scleroderma?","volume":"102","author":"Yamamoto","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/clim.2001.5138","article-title":"Animal model of sclerotic skin. V: increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma","volume":"102","author":"Yamamoto","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0906-6705.2005.00280.x","article-title":"Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective","volume":"14","author":"Yamamoto","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.jid.5700613","article-title":"Formation and function of the myofibroblast during tissue repair","volume":"127","author":"Hinz","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib33","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGFbeta signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajpath.2019.04.012_bib34","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI114866","article-title":"Tumor necrosis factor-alpha and interferon-gamma suppress the activation of human type I collagen gene expression by transforming growth factor-beta1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels","volume":"86","author":"Kahari","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2019.04.012_bib35","doi-asserted-by":"crossref","first-page":"30226","DOI":"10.1074\/jbc.M005310200","article-title":"Tumor necrosis factor-alpha inhibits transforming growth factor-beta\/Smad signaling in human dermal fibroblasts via AP-1 activation","volume":"275","author":"Verrecchia","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2019.04.012_bib36","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1136\/annrheumdis-2013-204516","article-title":"S100A4 amplifies TGF-beta-induced fibroblast activation in systemic sclerosis","volume":"74","author":"Tomcik","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajpath.2019.04.012_bib37","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1002\/art.24934","article-title":"A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis","volume":"60","author":"Hasegawa","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2019.04.012_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/mol.105.017483","article-title":"Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression","volume":"69","author":"Jinnin","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib39","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ejca.2011.06.043","article-title":"SMAD3 is essential for transforming growth factor-beta1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes","volume":"48","author":"Kocic","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2019.04.012_bib40","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.4049\/jimmunol.171.7.3855","article-title":"Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts","volume":"171","author":"Yamane","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1189\/jlb.0812429","article-title":"Insights into the role of progranulin in immunity, infection, and inflammation","volume":"93","author":"Jian","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajpath.2019.04.012_bib42","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12031-011-9569-4","article-title":"Structure, function, and mechanism of progranulin; the brain and beyond","volume":"45","author":"Toh","year":"2011","journal-title":"J Mol Neurosci"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944018309477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944018309477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:33:27Z","timestamp":1757694807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944018309477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0002944018309477"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2019.04.012","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progranulin Promotes Bleomycin-Induced Skin Sclerosis by Enhancing Transforming Growth Factor\u2013\u03b2\/Smad3 Signaling through Up-Regulation of Transforming Growth Factor\u2013\u03b2 Type I Receptor","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2019.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}